Top 3 Health Care Stocks That May Crash In May
Portfolio Pulse from Avi Kapoor
Three health care stocks, TransMedics Group, Inc. (TMDX), CareDx, Inc. (CDNA), and Heron Therapeutics, Inc. (HRTX), are identified as potentially overbought with high RSI values, indicating a possible short-term price decline. Despite recent strong financial results and significant stock gains, their momentum indicators suggest caution for investors.
May 24, 2024 | 11:53 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CareDx, Inc. (CDNA) reported better-than-expected financial results and significant stock gains, but its high RSI value of 76.48 suggests it may be overbought, indicating a potential short-term price decline.
Despite strong financial results and significant stock gains, the high RSI value indicates that the stock may be overbought, suggesting a potential short-term price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Heron Therapeutics, Inc. (HRTX) reported strong financial results and stock gains, but its high RSI value of 71.77 suggests it may be overbought, indicating a potential short-term price decline.
Despite strong financial results and stock gains, the high RSI value indicates that the stock may be overbought, suggesting a potential short-term price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
TransMedics Group, Inc. (TMDX) has shown strong financial performance and significant stock gains, but its high RSI value of 78.24 suggests it may be overbought, indicating a potential short-term price decline.
Despite strong quarterly results and raised guidance, the high RSI value indicates that the stock may be overbought, suggesting a potential short-term price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100